The DOI matches its Crossref record; 210 of the 210 references it cites were found in a registry or an index.
Ageing as a risk factor for neurodegenerative disease
Abstract
Ageing is the primary risk factor for most neurodegenerative diseases, including Alzheimer disease (AD) and Parkinson disease (PD). One in ten individuals aged ≥65 years has AD and its prevalence continues to increase with increasing age. Few or no effective treatments are available for ageing-related neurodegenerative diseases, which tend to progress in an irreversible manner and are associated with large socioeconomic and personal costs. This Review discusses the pathogenesis of AD, PD and other neurodegenerative diseases, and describes their associations with the nine biological hallmarks of ageing: genomic instability, telomere attrition, epigenetic alterations, loss of proteostasis, mitochondrial dysfunction, cellular senescence, deregulated nutrient sensing, stem cell exhaustion and altered intercellular communication. The central biological mechanisms of ageing and their potential as targets of novel therapies for neurodegenerative diseases are also discussed, with potential therapies including NAD+ precursors, mitophagy inducers and inhibitors of cellular senescence.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The use of primary human monocytes also has several advantages: (i) their human origin enables the study of human-specific disease phenotypes and molecular mechanisms, (ii) monocytes derived from patients with AD may contain cell-intrinsic properties specific to that patient, and (iii) monocytes derived from patients with AD and age-matched controls may exhibit age-relevant phenotypes, given that”
From Understanding monocyte-driven neuroinflammation in Alzheimer’s disease using human cortical organoid microphysiological systems (2025) · cites this paper as [75]
In the citing paper
“Aging, which remains the largest risk factor for LOAD, is associated with low-grade systemic inflammation (termed “inflammaging”) [20, 21].”
From Microglial function, INPP5D/SHIP1 signaling, and NLRP3 inflammasome activation: implications for Alzheimer’s disease (2023) · cites this paper as [21]
In the citing paper
“Age‐related alterations in the brain microenvironment gradually led to increased BBB permeability and leakiness, neuronal degeneration, production of reactive oxygen species (ROS) and inflammation. 54 , 55 , 56”
From Therapeutic Properties and Pharmacological Activities of Asiaticoside and Madecassoside: A Review (2023) · cites this paper as [54]
In the citing paper
“Aging is known to be the primary driver of many neurodegenerative diseases, including Alzheimer’s disease (AD) [53].”
From Senescence-related impairment of autophagy induces toxic intraneuronal amyloid-β accumulation in a mouse model of amyloid pathology (2023) · cites this paper as [53]
In the citing paper
“This concurrence could explain the strong link between increased age and ND [83].”
From Untangling senescent and damage‐associated microglia in the aging and diseased brain (2023) · cites this paper as [83]
In the citing paper
“Aging is the predominant risk factor for cognitive dysfunction (Kalache and Gatti, 2003; Partridge et al., 2018) and several neurodegenerative disorders, including Alzheimer's disease (AD) and Parkinson's disease (PD) (Hou et al., 2019; López-Otín et al., 2013; Niccoli et al., 2017).”
From Atlas of the aging mouse brain reveals white matter as vulnerable foci (2023) · cites this paper as Hou et al., 2019
Citations
Cites
2 retracted
RETRACTED ARTICLE: Parkin and PINK1 mitigate STING-induced inflammation
Sliter, D. A., Martinez, J., Hao, L., Chen, X., Sun, N., Fischer, T. D., Burman, J. L., Li, Y., Zhang, Z., Narendra, D. P., et al. (2018) · Nature · doi:10.1038/s41586-018-0448-9 · Cited by 1,287
RetractedValera, E., Spencer, B. J., Fields, J. A., Trinh, I., Adame, A., Mante, M., Rockenstein, E. M., Desplats, P., & Masliah, E. (2017) · Acta Neuropathologica Communications · doi:10.1186/s40478-016-0409-1 · Cited by 49
RetractedLópez-Otín, C., Blasco, M. A., Partridge, L., Serrano, M., & Kroemer, G. (2013) · Cell · doi:10.1016/j.cell.2013.05.039 · Cited by 14,982
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
Jack, C. R., Bennett, D. A., Blennow, K., Carrillo, M. C., Dunn, B., Haeberlein, S. B., Holtzman, D. M., Jagust, W., Jessen, F., Karlawish, J., et al. (2018) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.02.018 · Cited by 10,537
Kalia, L. V., & Lang, A. E. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61393-3 · Cited by 6,184
The amyloid hypothesis of Alzheimer's disease at 25 years
Selkoe, D. J., & Hardy, J. (2016) · EMBO Molecular Medicine · doi:10.15252/emmm.201606210 · Cited by 6,164
The limited in vitro lifetime of human diploid cell strains
Hayflick, L. (1965) · Experimental Cell Research · doi:10.1016/0014-4827(65)90211-9 · Cited by 5,876
Poewe, W., Seppi, K., Tanner, C. M., Halliday, G. M., Brundin, P., Volkmann, J., Schrag, A.-E., & Lang, A. E. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.13 · Cited by 5,415
The senescence-associated secretory phenotype: the dark side of tumor suppression
Coppé, J.-P., Desprez, P.-Y., Krtolica, A., & Campisi, J. (2010) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-121808-102144 · Cited by 5,206
Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy
Liu, C.-C., Kanekiyo, T., Xu, H., & Bu, G. (2013) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.263 · Cited by 3,459
Cited by
Sorted by citations
Items 201–300 of 1,007
The hallmarks of aging as a conceptual framework for health and longevity research
Tartiere, A. G., Freije, J. M. P., & López-Otín, C. (2024) · Frontiers in Aging · doi:10.3389/fragi.2024.1334261 · Cited by 108
Understanding exosomes: Part 2—Emerging leaders in regenerative medicine
Miron, R. J., Estrin, N. E., Sculean, A., & Zhang, Y. (2024) · Periodontology 2000 · doi:10.1111/prd.12561 · Cited by 89
Molecular insights of exercise therapy in disease prevention and treatment
Walzik, D., Chirino, T. Y. W., Zimmer, P., & Joisten, N. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01841-0 · Cited by 95
Metformin in therapeutic applications in human diseases: its mechanism of action and clinical study
Du, Y., Zhu, Y., Zhou, Y., Ding, J., & Liu, J. (2022) · Molecular Biomedicine · doi:10.1186/s43556-022-00108-w · Cited by 84
Ratan, Y., Rajput, A., Maleysm, S., Pareek, A., Jain, V. K., Pareek, A., Kaur, R., & Singh, G. (2023) · Biomedicines · doi:10.3390/biomedicines11051398 · Cited by 89
Culberson, J. W., Kopel, J. J., Sehar, U., & Reddy, P. H. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.102001 · Cited by 95
Spinocerebellar ataxia 27B: A novel, frequent and potentially treatable ataxia
Pellerin, D., Danzi, M. C., Renaud, M., Houlden, H., Synofzik, M., Zuchner, S. L., & Brais, B. (2024) · Clinical and Translational Medicine · doi:10.1002/ctm2.1504 · Cited by 83
A Blueprint for Characterizing Senescence
Roy, A. L., Sierra, F., Howcroft, K., Singer, D. S., Sharpless, N., Hodes, R. J., Wilder, E. L., & Anderson, J. M. (2020) · Cell · doi:10.1016/j.cell.2020.10.032 · Cited by 81
Jurcău, M. C., Jurcău, A., Cristian, A., Hogea, V. O., Diaconu, R. G., & Nunkoo, V. S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms251910535 · Cited by 100
Plasma proteomics identify biomarkers and undulating changes of brain aging
Liu, W., You, J., Chen, S.-D., Zhang, Y., Feng, J., Xu, Y., Yu, J., & Cheng, W. (2024) · Nature Aging · doi:10.1038/s43587-024-00753-6 · Cited by 90
Wu, M., Yang, X., Li, X., Duan, W., & Du, J. (2021) · Behavioural Brain Research · doi:10.1016/j.bbr.2021.113125 · Cited by 86
Unveiling the future: Advancements in MRI imaging for neurodegenerative disorders
Du, L., Roy, S., Wang, P., Li, Z., Qiu, X., Zhang, Y., Yuan, J., & Guo, B. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102230 · Cited by 83
Telomere transcription in ageing
Aguado, J., di Fagagna, F. D., & Wolvetang, E. J. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101115 · Cited by 81
Aging, Cellular Senescence, and Progressive Multiple Sclerosis
Papadopoulos, D., Magliozzi, R., Mitsikostas, D. D., Gorgoulis, V. G., & Nicholas, R. S. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00178 · Cited by 80
Selective autophagy as a therapeutic target for neurological diseases
Xu, W., Ocak, U., Gao, L., Tu, S., Lenahan, C., Zhang, J., & Shao, A. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03667-9 · Cited by 84
Evidence of sex differences in cellular senescence
Ng, M., & Hazrati, L. (2022) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2022.08.014 · Cited by 85
The role of sirtuin 1 in ageing and neurodegenerative disease: A molecular perspective
Thapa, R., Moglad, E. H. O., Afzal, M., Gupta, G., Bhat, A. A., Almalki, W. H., Kazmi, I. A., Alzarea, S. I., Pant, K., Singh, T. G., et al. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102545 · Cited by 87
Can COVID-19 pandemic boost the epidemic of neurodegenerative diseases?
Verkhratsky, A., Li, Q., Melino, S., Melino, G., & Shi, Y. (2020) · Biology Direct · doi:10.1186/s13062-020-00282-3 · Cited by 81
Role of glucagon-like peptide-1 receptor agonists in Alzheimer’s disease and Parkinson’s disease
Hong, C.-T., Chen, J.-H., & Hu, C.-J. (2024) · Journal of Biomedical Science · doi:10.1186/s12929-024-01090-x · Cited by 78
Neurovascular Inflammaging in Health and Disease
Mészáros, Á., Molnár, K., Nógrádi, B., Hernádi, Z., Nyúl‐Tóth, Á., Wilhelm, I., & Krizbai, I. A. (2020) · Cells · doi:10.3390/cells9071614 · Cited by 86
Dörfel, R. P., Arenas‐Gomez, J. M., Fisher, P. M., Ganz, M., Knudsen, G. M., Svensson, J. E., & Plavén‐Sigray, P. (2023) · Human Brain Mapping · doi:10.1002/hbm.26502 · Cited by 85
Caenorhabditis elegans as a Model System to Study Human Neurodegenerative Disorders
Roussos, A., Kitopoulou, K., Borbolis, F., & Palikaras, K. (2023) · Biomolecules · doi:10.3390/biom13030478 · Cited by 82
Neural ageing and synaptic plasticity: prioritizing brain health in healthy longevity
Navakkode, S., & Kennedy, B. K. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1428244 · Cited by 75
Advances in protein-protein interaction network analysis for Parkinson's disease
Tomkins, J. E., & Manzoni, C. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105395 · Cited by 78
The Positive Role and Mechanism of Herbal Medicine in Parkinson’s Disease
Yin, R. L., Xue, J., Tan, Y., Fang, C., Hu, C., Yang, Q., Mei, X., & Qi, D. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/9923331 · Cited by 82
Synaptic Mitochondria: An Early Target of Amyloid-β and Tau in Alzheimer’s Disease
Torres, A. K., Jara, C., Park-Kang, H. S., Polanco, C. M., Tapia, D., Alarcón, F., de la Peña, A., Llanquinao, J., Vargas-Mardones, G., Álvarez‐Indo, J., et al. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-215139 · Cited by 80
Goldoni, R., Dolci, C., Boccalari, E., Inchingolo, F., Paghi, A., Strambini, L. M., Galimberti, D., & Tartaglia, G. M. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101587 · Cited by 86
Mitochondrial dysfunction is a key pathological driver of early stage Parkinson’s
Toomey, C. E., Heywood, W., Evans, J. R., Lachica, J., Pressey, S. N., Foti, S. C., Shahrani, M. M. A., D’Sa, K., Hargreaves, I. P., Heales, S., et al. (2022) · Acta Neuropathologica Communications · doi:10.1186/s40478-022-01424-6 · Cited by 77
St‐Pierre, M., Carrier, M., Ibáñez, F. G., Šimončičová, E., Wallman, M., Vallières, L., Parent, M., & Tremblay, M. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02595-8 · Cited by 80
Jung, B.-K., & Ryu, K. (2023) · Experimental & Molecular Medicine · doi:10.1038/s12276-023-01098-7 · Cited by 76
Munawara, U., Catanzaro, M., Xu, W., Tan, C., Hirokawa, K., Bosco, N., Dumoulin, D., Khalil, A., Larbi, A., Lévesque, S., et al. (2021) · Immunity & Ageing · doi:10.1186/s12979-021-00236-x · Cited by 74
Tello, J. A., Williams, H., Eppler, R., Steinhilb, M. L., & Khanna, M. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.883358 · Cited by 77
Regulation of Mitophagy by Sirtuin Family Proteins: A Vital Role in Aging and Age-Related Diseases
Wan, W., Hua, F., Fang, P., Li, C., Deng, F., Chen, S., Ying, J., & Wang, X. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.845330 · Cited by 79
Melatonin as an Anti-Aging Therapy for Age-Related Cardiovascular and Neurodegenerative Diseases
Giménez, V. M. M., Heras, N. D. L., Lahera, V., Tresguerres, J. A. F., Reiter, R. J., & Manucha, W. A. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.888292 · Cited by 75
Role of mitochondria in physiological activities, diseases, and therapy
Wang, L., Zhou, X., & Lu, T. (2025) · Molecular Biomedicine · doi:10.1186/s43556-025-00284-5 · Cited by 87
Anti‐inflammatory treatment rescues memory deficits during aging in nfkb1−/− mice
Fielder, E., Tweedy, C., Wilson, C., Oakley, F., LeBeau, F. E. N., Passos, J. F., Mann, D. A., von Zglinicki, T., & Jurk, D. (2020) · Aging Cell · doi:10.1111/acel.13188 · Cited by 71
Mitophagy and DNA damage signaling in human aging
Babbar, M., Basu, S., Yang, B., Croteau, D. L., & Bohr, V. A. (2020) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2020.111207 · Cited by 77
Self-citationNicaise, A. M., Willis, C. M., Crocker, S. J., & Pluchino, S. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.00247 · Cited by 76
Peng, B., Tong, Z., Tong, W. Y., Pasic, P. J., Oddo, A., Dai, Y., Luo, M., Frescene, J., Welch, N. G., Easton, C. D., et al. (2020) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.0c17102 · Cited by 74
Regulators of cholinergic signaling in disorders of the central nervous system
Winek, K., Soreq, H., & Meisel, A. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15332 · Cited by 75
Kim, Y. J., Soto, M., Branigan, G. L., Rodgers, K. E., & Brinton, R. D. (2021) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1002/trc2.12174 · Cited by 73
Propagation of tau and α-synuclein in the brain: therapeutic potential of the glymphatic system
Lopes, D. M., Llewellyn, S. K., & Harrison, I. F. (2022) · Translational Neurodegeneration · doi:10.1186/s40035-022-00293-2 · Cited by 75
Chandramowlishwaran, P., Vijay, A., Abraham, D., Li, G., Mwangi, S. M., & Srinivasan, S. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.614331 · Cited by 74
Astrocyte senescence and SASP in neurodegeneration: tau joins the loop
Ungerleider, K., Beck, J. A., Lissa, D., Turnquist, C., Horikawa, I., Harris, B. T., & Harris, C. C. (2021) · Cell Cycle · doi:10.1080/15384101.2021.1909260 · Cited by 72
Olesen, M. A., Villavicencio-Tejo, F., & Quintanilla, R. A. (2022) · Translational Neurodegeneration · doi:10.1186/s40035-022-00308-y · Cited by 80
Turrini, S., Wong, B., Eldaief, M. C., Press, D. Z., Sinclair, D. A., Koch, G., Avenanti, A., & Santarnecchi, E. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.101939 · Cited by 88
Current views on meningeal lymphatics and immunity in aging and Alzheimer’s disease
Rego, S., Sánchez, G., & Mesquita, S. D. (2023) · Molecular Neurodegeneration · doi:10.1186/s13024-023-00645-0 · Cited by 79
Bocheva, G., Bakalov, D. V., Iliev, P., & Tafradjiiska-Hadjiolova, R. K. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25105122 · Cited by 86
The gut microbiota and aging: interactions, implications, and interventions
Gyriki, D., Nikolaidis, C. G., Bezirtzoglou, E., Voidarou, C. C., Stavropoulou, E., & Tsigalou, C. (2025) · Frontiers in Aging · doi:10.3389/fragi.2025.1452917 · Cited by 80
TDP-43 and Inflammation: Implications for Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
Bright, F., Chan, G., van Hummel, A., Ittner, L. M., & Ke, Y. D. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22157781 · Cited by 71
Necroptosis increases with age in the brain and contributes to age-related neuroinflammation
Thadathil, N., Nicklas, E. H., Mohammed, S., Lewis, T. L., Richardson, A. G., & Deepa, S. S. (2021) · GeroScience · doi:10.1007/s11357-021-00448-5 · Cited by 74
Multiscale Mechanobiology in Brain Physiology and Diseases
Procès, A., Luciano, M., Kalukula, Y., Ris, L., & Gabriele, S. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.823857 · Cited by 73
Peng, W., Zhou, R., Sun, Z., Long, J.-W., & Gong, Y.-Q. (2022) · Aging and Disease · doi:10.14336/ad.2021.0928 · Cited by 73
Microglial Activation and Oxidative Stress in PM2.5-Induced Neurodegenerative Disorders
Song, J., Han, K., Wang, Y., Qu, R., Liu, Y., Wang, S., Wang, Y., An, Z., Li, J., Wu, H., et al. (2022) · Antioxidants · doi:10.3390/antiox11081482 · Cited by 79
Presbyphagia: Dysphagia in the elderly
Feng, H.-Y., Zhang, P.-P., & Wang, X. (2023) · World Journal of Clinical Cases · doi:10.12998/wjcc.v11.i11.2363 · Cited by 85
Pathological and Inflammatory Consequences of Aging
García‐Domínguez, M. (2025) · Biomolecules · doi:10.3390/biom15030404 · Cited by 78
Hrelia, P., Sita, G., Ziche, M., Ristori, E., Marino, A., Cordaro, M., Molteni, R., Spero, V., Malaguti, M., Morroni, F., et al. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/8363245 · Cited by 73
Dysregulated Wnt Signalling in the Alzheimer’s Brain
Aghaizu, N. D., Jin, H., & Whiting, P. J. (2020) · Brain Sciences · doi:10.3390/brainsci10120902 · Cited by 70
Telehealth in Neurodegenerative Diseases: Opportunities and Challenges for Patients and Physicians
Marchi, F. D., Contaldi, E., Magistrelli, L., Cantello, R. M., Comi, C., & Mazzini, L. (2021) · Brain Sciences · doi:10.3390/brainsci11020237 · Cited by 74
Wodrich, A. P. K., Scott, A. W., Shukla, A. K., Harris, B. T., & Giniger, E. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.831116 · Cited by 73
Ribarič, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23063245 · Cited by 77
Kluever, V., Russo, B., Mandad, S., Kumar, N. H., Alevra, M., Ori, A., Rizzoli, S. O., Urlaub, H., Schneider, A., & Fornasiero, E. F. (2022) · Science Advances · doi:10.1126/sciadv.abn4437 · Cited by 73
Fasting: From Physiology to Pathology
Tang, D., Tang, Q., Huang, W., Zhang, Y., Tian, Y., & Fu, X. (2023) · Advanced Science · doi:10.1002/advs.202204487 · Cited by 74
Elevation of ACE2 as a SARS-CoV-2 entry receptor gene expression in Alzheimer's disease
Lim, K., Yang, S., Kim, S., & Joo, J. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.06.072 · Cited by 70
Mechanisms Linking Mitochondrial Dysfunction and Proteostasis Failure
Lu, B., & Guo, S. (2020) · Trends in Cell Biology · doi:10.1016/j.tcb.2020.01.008 · Cited by 69
Liang, Z., Currais, A. J. M., Soriano‐Castell, D., Schubert, D. A., & Maher, P. A. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107749 · Cited by 71
Psenicka, M. W., Smith, B. C., Tinkey, R. A., & Williams, J. L. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.654284 · Cited by 73
Exercise and gait/movement analyses in treatment and diagnosis of Parkinson’s Disease
Burtscher, J., Moraud, E. M., Malatesta, D., Millet, G. P., Bally, J. F., & Patoz, A. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.102147 · Cited by 76
Xie, Y. R., Castro, D. C., Rubakhin, S. S., Trinklein, T. J., Sweedler, J. V., & Lam, F. (2024) · Nature Methods · doi:10.1038/s41592-024-02171-3 · Cited by 74
Frailty Trajectories Preceding Dementia in the US and UK
Ward, D. D., Flint, J. P., Littlejohns, T. J., Foote, I. F., Canevelli, M., Wallace, L. M. K., Gordon, E. H., Llewellyn, D. J., Ranson, J. M., Hubbard, R. E., et al. (2024) · JAMA Neurology · doi:10.1001/jamaneurol.2024.3774 · Cited by 79
Untangling senescent and damage‐associated microglia in the aging and diseased brain
Ng, P. Y., McNeely, T. L., & Baker, D. J. (2023) · The FEBS Journal · doi:10.1111/febs.16315 · Cited by 68
Alzheimer’s and Parkinson’s Diseases Predict Different COVID-19 Outcomes: A UK Biobank Study
Yu, Y., Travaglio, M., Popovic, R., Leal, N. S., & Martins, L. M. (2021) · Geriatrics · doi:10.3390/geriatrics6010010 · Cited by 69
Transposable elements as new players in neurodegenerative diseases
Ravel‐Godreuil, C., Znaidi, R., Bonnifet, T., Joshi, R. L., & Fuchs, J. (2021) · FEBS Letters · doi:10.1002/1873-3468.14205 · Cited by 77
Protein aggregation and therapeutic strategies in SOD1- and TDP-43- linked ALS
Tsekrekou, M., Giannakou, M., Papanikolopoulou, K., & Σκρέτας, Γ. (2024) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2024.1383453 · Cited by 71
Groh, J., Feng, R., Yuan, X., Liu, L., Klein, D., Hutahaean, G., Butz, E. S., Wang, Z., Steinbrecher, L., Neher, J. J., et al. (2025) · Nature Neuroscience · doi:10.1038/s41593-025-01955-w · Cited by 81
Peña‐Bautista, C., Casas-Fernández, E., Vento, M., Baquero, M., & Cháfer‐Pericás, C. (2020) · Clinica Chimica Acta · doi:10.1016/j.cca.2020.01.019 · Cited by 70
Role of exosomes in the pathogenesis of inflammation in Parkinson’s disease
Yang, X., Li, K., Huang, H., & Ren, H. (2022) · Neural Regeneration Research · doi:10.4103/1673-5374.335143 · Cited by 68
Diniz, C. R. A. F., & Crestani, A. P. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01931-x · Cited by 77
Tseng, Y.-L., Lu, P.-C., Lee, C.-C., He, R., Huang, Y., Tseng, Y., Cheng, T.-J. R., Huang, J. J., & Fang, J. (2023) · Journal of Biomedical Science · doi:10.1186/s12929-023-00921-7 · Cited by 73
Mentis, A. A., Dardiotis, E., Efthymiou, V., & Chrousos, G. P. (2021) · BMC Medicine · doi:10.1186/s12916-020-01873-7 · Cited by 85
Kovács, Z., Brunner, B., & Ari, C. (2021) · Nutrients · doi:10.3390/nu13072197 · Cited by 68
Ghavami, T., Kazeminia, M., Ahmadi, N., & Rajati, F. (2023) · Journal of PeriAnesthesia Nursing · doi:10.1016/j.jopan.2023.01.018 · Cited by 69
Calì, C., Cantando, I., Veloz Castillo, M. F., Gonzalez, L., & Bezzi, P. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25168922 · Cited by 66
A synergetic turn in cognitive neuroscience of brain diseases
Ibanez, A., Kringelbach, M. L., & Deco, G. (2024) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2023.12.006 · Cited by 65
Squitti, R., Faller, P., Hureau, C., Granzotto, A., White, A. R., & Kepp, K. P. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-201556 · Cited by 67
The Role of AhR in the Hallmarks of Brain Aging: Friend and Foe
Ojo, E. S., & Tischkau, S. A. (2021) · Cells · doi:10.3390/cells10102729 · Cited by 79
The potential of hyperbaric oxygen as a therapy for neurodegenerative diseases
Mensah-Kane, P., & Sumien, N. (2022) · GeroScience · doi:10.1007/s11357-022-00707-z · Cited by 65
Ageing in the brain: mechanisms and rejuvenating strategies
Gaspar-Silva, F., Trigo, D., & Magalhães, J. (2023) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-023-04832-6 · Cited by 88
Clinical perspectives on the age-related increase of immunosuppressive activity
Salminen, A. (2022) · Journal of Molecular Medicine · doi:10.1007/s00109-022-02193-4 · Cited by 57
Zhang, J., Chen, K., Zhou, Y., Wei, H., Qi, M.-H., Wang, Z., Zheng, Y., Chen, R., Liu, S., & Li, W. (2022) · Phytomedicine · doi:10.1016/j.phymed.2022.154341 · Cited by 64
Dance movement therapy for neurodegenerative diseases: A systematic review
Wu, C.-C., Xiong, H.-Y., Zheng, J., & Wang, X. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.975711 · Cited by 76
Methionine restriction - Association with redox homeostasis and implications on aging and diseases
Zhang, Y., Jelleschitz, J., Grune, T., Chen, W., Zhao, Y., Jia, M., Wang, Y., Liu, Z., & Höhn, A. (2022) · Redox Biology · doi:10.1016/j.redox.2022.102464 · Cited by 72
Role of estrogen in women's Alzheimer's disease risk as modified by APOE
Valencia‐Olvera, A. C., Weng, J. M., Christensen, A., LaDu, M. J., & Pike, C. J. (2022) · Journal of Neuroendocrinology · doi:10.1111/jne.13209 · Cited by 75
Xu, H. M., Liu, Y., Li, L.-S., & Liu, Y. (2023) · Aging and Disease · doi:10.14336/ad.2022.1123 · Cited by 69
Zeng, S.-Y., Liu, Y., Liu, J., Zeng, Z., Xie, H., & Liu, J. (2023) · Aging and Disease · doi:10.14336/ad.2023.0325 · Cited by 67
Allostatic Interoceptive Overload Across Psychiatric and Neurological Conditions
Santamaría-García, H., Migeot, J., Medel, V., Hazelton, J. L., Teckentrup, V., Romero-Ortuno, R., Piguet, O., Lawor, B., Northoff, G., & Ibanez, A. (2025) · Biological Psychiatry · doi:10.1016/j.biopsych.2024.06.024 · Cited by 65
BCL2L13: physiological and pathological meanings
Meng, F., Sun, N., Liu, D., Jia, J., Xiao, J., & Dai, H. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03702-9 · Cited by 63
Sources and triggers of oxidative damage in neurodegeneration
Angelova, P. R. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.07.003 · Cited by 67
Kosti, R. I., Kasdagli, M., Kyrozis, A., Orsini, N., Λάγιου, Π., Taiganidou, F., & Naska, A. (2021) · Nutrition Reviews · doi:10.1093/nutrit/nuab078 · Cited by 63
Natural products for the treatment of neurodegenerative diseases
Cui, D., Chen, Y., Ye, B., Guo, W., Wang, D., & He, J. (2023) · Phytomedicine · doi:10.1016/j.phymed.2023.155101 · Cited by 71
Metadata
- Authors
- Hou, Y., Dan, X., Babbar, M., Wei, Y., Hasselbalch, S. G., Croteau, D. L., & Bohr, V. A.
- Affiliations
- National Institute on Aging (US)
- University of Copenhagen (DK)
- Corresponding author
- Bohr, Vilhelm A.
- ORCID
- Venue
- Nature Reviews Neurology
- Published
- 2019-09-09
- Volume
- 15
- Issue
- 10
- Pages
- 565-581
- ISSN
- 1759-4758 (ISSN-L)
- 1759-4766
- OpenAlex
- W2972368830
- Semantic Scholar
- 4f2aec225c7ce5314a73bd30acc5348f6086766b
- Cited by
- 3,310
- References
- 209
- Citations by year
- 2026: 441 · 2025: 639 · 2024: 675 · 2023: 534 · 2022: 474 · 2021: 359 · 2020: 178 · 2019: 8
- FWCI
- 22.06
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Nature Reviews Neurology (publishedVersion)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
- Funders
- National Institute on Aging
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- aging, neurodegenerative diseases, Alzheimer's disease, Parkinson's disease, genomic instability, telomere shortening, epigenetic modifications, proteostasis, mitochondrial dysfunction, cellular senescence, nutrient sensing, stem cell exhaustion, intercellular communication, NAD+ precursors, mitophagy, senolytics, therapeutic target
- MeSH terms
- Aging, Brain, DNA Damage, Humans, Risk Factors, Neurodegenerative Diseases, Epigenesis, Genetic, Mitophagy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
